Less can be more: A finite treatment approach for HBeAg-negative chronic hepatitis B-Reference-Cited by-同舟云学术

Less can be more: A finite treatment approach for HBeAg-negative chronic hepatitis B

Published:2018-05-14 Issue:2 Volume:68 Page:397-400
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lampertico Pietro¹^ORCID,Berg Thomas²

Affiliation:

1. CRC “A.M. e A. Migliavacca” Center for the Study of Liver Disease Division of Gastroenterology and Hepatology Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico; Università degli Studi di Milano; Milan Italy

2. Section of Hepatology Clinic and Polyclinic for Gastroenterology and Rheumatology; University Clinic Leipzig; Leipzig Germany

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29821/fullpdf

Reference8 articles.

1. AASLD guidelines for treatment of chronic hepatitis B;Terrault;Hepatology,2016

2. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update;Sarin;Hepatol Int,2016

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2017

4. Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B;Papatheodoridis;Hepatology,2018

5. Incidence and predictors of HBsAg seroclearance after cessation of nucleos(t)ide analogue therapy in HBeAg negative chronic hepatitis B;Jeng;Hepatology,2018

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study);American Journal of Gastroenterology;2024-05-14

2. Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers;PLOS Computational Biology;2024-03-11

3. Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study;Clinics and Research in Hepatology and Gastroenterology;2024-02

4. Long Term HBsAg Responses to Peg-Interferon Alpha-2b in HBeAg Negative Chronic Hepatitis B Patients Developing Clinical Relapse after Stopping Long-Term Nucleos(t)ide Analogue Therapy;Journal of Clinical and Experimental Hepatology;2024-01

5. Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm;Clinical and Molecular Hepatology;2023-10-01